Infectious Diseases
COVID-19 Prevention
Patient Care Perspectives Podcast: Assessing Exposure Risk and Discussing Early Prevention Options With Patients
For patients with known or possible COVID-19 exposure, Anthony Cheng, MD, MBA, emphasizes a practical risk-based approach that starts with clarifying the likelihood of transmission and the likelihood of progression to severe illness. In this podcast, Dr Cheng discusses how primary care clinicians can frame exposure risk, use serial rapid antigen testing when results will guide action, reinforce prevention measures during ongoing household exposure, and distinguish postexposure prophylaxis from treatment once a patient tests positive for COVID-19.
Hayden FG, Shinkai M, Clark TW, et al; SCORPIO-PEP Study Team. Ensitrelvir for Covid-19 postexposure prophylaxis in household contacts. N Engl J Med. 2026;394(19):1905-1915. doi:10.1056/NEJMoa2509306
Marzolini C, Kuritzkes DR, Marra F, et al. Recommendations for the management of drug-drug interactions between the COVID-19 antiviral nirmatrelvir/ritonavir (Paxlovid) and comedications. Clin Pharmacol Ther. 2022;112(6):1191-1200. doi:10.1002/cpt.2646
Shumaker AH, Bhimraj A, Bedimo R, et al. 2025 clinical practice guideline update by the Infectious Diseases Society of America on the treatment and management of COVID-19: antiviral treatment for mild to moderate COVID-19 in adults. Clin Infect Dis. 2026;82(suppl 3):i1-i17. doi:10.1093/cid/ciaf680
Soni A, Herbert C, Lin H, et al. Performance of rapid antigen tests to detect symptomatic and asymptomatic SARS-CoV-2 infection: a prospective cohort study. Ann Intern Med. 2023;176(7):975-982. doi:10.7326/M23-0385
Explore More in COVID-19 Prevention
COVID-19 Prevention
